Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01563172 · ClinicalTrials.gov registry record · Phase 4
Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride
A Phase 4 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 4
- Development phase
- 65
- Enrollment target
NCT01563172 is a Phase 4 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 65 participants.
The verdict
NCT01563172, a Phase 4 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 65 participants
- Enrollment target
Study Summary
This study will evaluate and compare the effect of the amount of toothpaste used and brushing time on enamel strengthening (percent of surface microhardness recovery, % SMHR) and enamel fluoride uptake (EFU).
Interventions
- DRUG Sodium fluoride / silica and carbopol, 0.5g
- DRUG Sodium fluoride / silica and carbopol, 1.5g
- OTHER Fluoride free dentifrice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2009-01-01 |
| Est. Completion | 2009-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01563172
The ClinicalTrials.gov registry entry for NCT01563172 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sodium fluoride / silica and carbopol, 0.5g is the first listed.
NCT01563172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01563172 about?
NCT01563172 is a clinical study titled "Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride". This study will evaluate and compare the effect of the amount of toothpaste used and brushing time on enamel strengthening (percent of surface microhardness recovery, % SMHR) and enamel fluoride uptake (EFU).
What is the current status of trial NCT01563172?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 65 participants. The study started on 2009-01-01. Estimated completion is 2009-06-01.
What interventions are being tested in trial NCT01563172?
The interventions under investigation include: Sodium fluoride / silica and carbopol, 0.5g (DRUG), Sodium fluoride / silica and carbopol, 1.5g (DRUG), Fluoride free dentifrice (OTHER).
Who is sponsoring clinical trial NCT01563172?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.